A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
Clinical trial NCT04461600 · TERMINATED
Trial details
- NCT number
- NCT04461600
- Sponsor
- Ayala Pharmaceuticals, Inc,
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-14
- Primary completion
- 2022-03-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.